Search
1,3,5-Tri-O-benzoyl-2-O-methyl-D-ribose is a specialized protected sugar intermediate essential for synthesizing antiviral and anticancer nucleoside analogs. Featuring benzoyl groups at positions 1, 3, and 5 plus a 2-O-methyl modification, it offers superior regioselectivity and stereochemical control. Key selling points include exceptional purity (>98%), ensuring high yields in complex pharmaceutical manufacturing. Its robust protecting group strategy facilitates precise downstream modifications, saving researchers significant time versus in-house synthesis. We provide full regulatory documentation (COA, SDS) and scalable supply from grams to kilograms, guaranteeing traceability and compliance for industrial R&D. Sold strictly as a non-finished chemical raw material for legal industrial use only; direct human or animal application is prohibited. Ideal for CROs and pharma companies requiring reliable, high-quality building blocks.
Chemical Structure: It is a derivative of D-Ribose where:
The hydroxyl group (-OH) at the 2-position is methylated (-OCH₃), which locks its chemical properties or influences stereochemistry.
The hydroxyl groups at the 1, 3, and 5-positions are protected with benzoyl groups (-COC₆H₅). Benzoyl groups are common protecting groups that prevent unwanted side reactions at these positions during subsequent synthetic steps and can be removed under specific conditions.
Primary Applications: It serves as a crucial organic synthesis intermediate, primarily in the pharmaceutical and biotechnology sectors for synthesizing:
Nucleoside Analogs: As a building block for creating bioactive nucleoside derivatives (e.g., antiviral drugs, anticancer agents).
Oligonucleotides: For research into RNA/DNA analogs.
Chiral Synthesis: Due to its specific stereochemical configuration, it is valuable in asymmetric synthesis for introducing chiral centers.
High Regioselectivity and Stereochemical Purity:
Offers high-purity specific alpha or beta isomers (e.g., >98% or >99% by HPLC), ensuring stereospecificity in downstream synthesis, minimizing byproducts, and improving the yield of final drug candidates.
Essential Synthetic Building Block:
An indispensable "brick" for synthesizing various blockbuster drugs (such as certain antiviral nucleoside medications). Given the complexity of its synthesis, purchasing high-quality ready-made material is often more cost-effective and time-efficient than in-house production.
Robust Protecting Group Strategy:
The benzoyl protecting groups offer excellent stability under various reaction conditions, while the 2-O-methylation provides a unique window of reactivity, allowing chemists to perform targeted modifications at specific sites.
Regulatory Compliance and Traceability:
Supplied with comprehensive documentation, including Certificates of Analysis (COA), Material Safety Data Sheets (MSDS/SDS), and detailed impurity profiles, meeting GMP or stringent research-grade standards to satisfy pharmaceutical industry audit requirements.
Scalable Supply Capability:
Capable of supporting scale-up from gram-level R&D to kilogram or even ton-level commercial production, ensuring a reliable supply chain for clients' evolving needs.



Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail:
English
Español
français
العربية